Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2010 | 09-2007 | 09-2006 | |
| Sales | 22,763 | 0 | 0 |
| Gross Profit | 22,763 | N/A | N/A |
| Operating Expenses | 15,821 | 0 | 0 |
| Operating Income | 6,942 | N/A | N/A |
| Other Income | 805 | 0 | 0 |
| Pre-tax Income | 7,747 | 0 | 0 |
| Income Tax | -157 | N/A | N/A |
| Net Income Continuous | 7,904 | N/A | N/A |
| Net Income | $7,904 | $N/A | $N/A |
| EPS Basic Total Ops | 0.19 | N/A | N/A |
| EPS Basic Continuous Ops | 6.99 | N/A | N/A |
| EPS Diluted Total Ops | 0.18 | N/A | N/A |
| EPS Diluted Continuous Ops | 5.05 | N/A | N/A |
| EBITDA(a) | $7,495 | $N/A | $N/A |